**BioMarin Pharmaceutical Inc. Update – October 27, 2025, 5:13 PM ET**
BioMarin Pharmaceutical Inc. continues to lead in the biotech industry, with its most profitable treatment driving significant growth.
—
**Stock Overview: BMRN**
| Metric | Value |
|—————|—————-|
| Last Price | [Insert Price] |
| % Change 1D | [Insert %] |
| % Change 5D | [Insert %] |
| % Change 1M | [Insert %] |
| % Change 6M | [Insert %] |
| % Change 1Y | [Insert %] |
| % Change 5Y | [Insert %] |
| % Change 10Y | [Insert %] |
| Market Cap | [Insert Value] |
| PE Ratio | [Insert Value] |
| Dividend Yield| [Insert %] |
| Revenue Growth (YoY) | [Insert %] |
| Short Interest| [Insert Value] |
| Previous Close| [Insert Price] |
—
**Trending Analysis and News**
BioMarin (BMRN) remains a trending stock, attracting investor attention due to its innovative pipeline and financial performance. Stay tuned for the latest news and updates on BioMarin’s progress and market movements.
—
*Recommended For You:*
– More Trending News About BMRN
– Related Stocks and Market Analysis
—
*Note: Please replace placeholders with the latest real-time data before publishing.*
https://seekingalpha.com/news/4509041-biomarin-seeks-divest-hemophilia-a-gene-therapy-roctavian?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news